Q32 Bio (QTTB) Return on Sales Growth (3y) (2021 - 2024)

Q32 Bio (QTTB) Return on Sales Growth (3y) (2021 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Q32 Bio 225.00 Mn 174.25 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 62.00
Jun 30, 2024 -97.00
Mar 31, 2024 -12.00
Dec 31, 2023 178.00
Sep 30, 2023 80.00
Jun 30, 2023 100.00
Mar 31, 2023 91.00
Dec 31, 2022 60.00
Sep 30, 2022 88.00
Jun 30, 2022 111.00
Mar 31, 2022 410.00
Dec 31, 2021 30.00
Sep 30, 2021 16.00
Jun 30, 2021 20.00
Mar 31, 2021 37.00